Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic

The COVID-19 pandemic has raised considerable concerns that patients with inflammatory bowel disease (IBD), particularly those treated with immunosuppressive therapies, may have an increased risk of SARS-CoV-2 acquisition, develop worse outcomes following COVID-19, and have suboptimal vaccine respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Simeng, Lau, Louis HS, Chanchlani, Neil, Kennedy, Nicholas A, Ng, Siew C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Recent Advances in Clinical Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185820/
https://www.ncbi.nlm.nih.gov/pubmed/35477864
http://dx.doi.org/10.1136/gutjnl-2021-326784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185820/
https://www.ncbi.nlm.nih.gov/pubmed/35477864
http://dx.doi.org/10.1136/gutjnl-2021-326784

Ejemplares similares